COVID survivors may be at higher risk for obstructive sleep apnea for up to 4.5 years post-infection
OSA is estimated to affect 10% to 30% of adults worldwide. It’s characterized by repeated upper-airway collapse during sleep, ...
IFLScience on MSN
Brain scans of recovered COVID-19 patients reveal microstructural and chemical changes
COVID-19 may leave a lasting impression on the brain, even in people who fully recover from their infection. New research reveals that even in those without the ongoing symptoms of long COVID, there ...
A detailed analysis of immune cells in Long COVID patients has revealed a previously unknown molecular signature linked to ...
Unvaccinated patients were 5.54 times more likely to die in the hospital. Patients vaccinated against COVID-19 who caught the virus -- and were hospitalized with reduced kidney function -- had better ...
Erica Hayes, 40, has not felt healthy since November 2020 when she first fell ill with COVID. Hayes is too sick to work, so she has spent much of the last four years sitting on her beige couch, often ...
Healthcare workers hold a tablet in front of a COVID-19 coronavirus patient during a video call with relatives at the Intensive Unit Care (ICU) of the Ramon y Cajal Hospital in Madrid on April 14, ...
11hon MSN
Hospitals with advanced IT and trial participation cut COVID-19 mortality faster, study finds
There's an unsung success story about the first year of the COVID-19 pandemic. At its outset, U.S. hospitals faced huge ...
The increased size of, and lesser blood supply to, a key brain structure in patients with long COVID tracks with known blood markers of Alzheimer's disease and greater levels of dementia, a new study ...
Researchers at New York University Langone Health have found a link between long COVID and Alzheimer’s-like symptoms in people’s brains in new study.
Rajkumar Dasgupta, MD, is the associate program director of Internal Medicine Residency at Huntington Health in Pasadena, California, and associate professor of medicine at the University of ...
Researchers are launching a new study to investigate whether GLP-1 drugs, already approved for type 2 diabetes and obesity, could help treat long COVID symptoms. The medications are currently being ...
With the many debilitating symptoms of long COVID, diet often takes a backseat to medication or supplements. However, "the [COVID-19] virus activates your whole immune system, and we have most of our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results